Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (95609)	3/9/2010 10:06:51 AM
From: diddlysquatz	Respond to of 120415

EDAP on fire this morning. High of $4.25 so far currently up 63% on the day EDAP Receives Japanese Approval for Sonolith I-Sys Enters Largest Global Lithotripsy Market LYON, France, Mar 9, 2010 (GlobeNewswire via COMTEX) -- EDAP TMS SA /quotes/comstock/15*!edap/quotes/nls/edap (EDAP 4.04, +1.53, +60.64%) , the global leader in therapeutic ultrasound, announced today that the Japanese Administration has granted marketing approval of its newly designed, high-end Sonolith I-Sys lithotripsy device. The lithotripsy market in Japan ranks number one worldwide in both total lithotripsy sales volume and installed base. Physicians in Japan have been historically quick to adopt new innovative, high-end devices. As the latest device to enter the Japanese market, the Sonolith I-Sys is an easy to use and effective tool that delivers benefits to both patients and physicians. With unique, integrated and robotized features, Sonolith I-Sys fully addresses the Japanese lithotripsy market demands for new high-end technologies. Marc Oczachowski, EDAP's Chief Executive Officer, commented, "Japan is the largest global lithotripsy market and the latest key territory we have received approval for Sonolith I-Sys. This approval is a major milestone and further validates EDAP's position as a major worldwide player in the lithotripsy field, with Sonolith I-Sys approved in all lithotripsy markets in the world. We are very enthusiastic with the Japanese approval of our Sonolith I-sys lithotripter. We are convinced that our innovative, high-end device perfectly suits the Japanese lithotripsy market and will allow us to successfully address the strong demand of major clinical centres and University hospitals. We are all the more excited as the approval coincides with the upcoming annual Japanese Urology Association (JAU) Congress, to be held in Morioka on April 27-30, 2010. At the event, our Sonolith I-sys will be highlighted and introduced as the latest innovative lithotripsy device." Marc Oczachowski continued, "The Japanese marketing approval will significantly contribute to our business development efforts in Japan as our sales and marketing team is already focusing its efforts in aggressively promoting our device to the medical community." Sonolith I-Sys has been actively promoted in Europe and the U.S. territory and is now available for sale in Japan. In 2007, Sonolith I-Sys lithotripsy device received initial marketing approval in Europe. As part of EDAP's strategy to introduce Sonolith I-Sys to leading global lithotripsy markets, the device successfully obtained marketing clearance by the U.S. FDA in August 2009 and the Japanese Administration in March 2010. About EDAP TMS SA EDAP TMS SA develops and markets Ablatherm, the most advanced and clinically proven choice for high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer. HIFU treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects. Ablatherm-HIFU is generally recommended for patients with localized prostate cancer (stages T1-T2) who are not candidates for surgery or who prefer an alternative option, or for patients who failed radiotherapy treatment. Approved in Europe as a treatment for prostate cancer, Ablatherm-HIFU (High Intensity Focused Ultrasound) is currently undergoing evaluation in a multicenter U.S. Phase II/III clinical trial under an Investigational Device Exemption granted by the FDA, the ENLIGHT U.S. clinical study. The Company also is developing this technology for the potential treatment of certain other types of tumors. EDAP TMS SA also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the company, please visit edap-tms.com, hifu-planet.com and pcaresearch.com.

To: GARY P GROBBEL who wrote (95609)	3/9/2010 10:17:06 AM
From: GARY P GROBBEL	Read Replies (1) \| Respond to of 120415

GWSC.OB .28....techs might be turning up here.... GWS Technologies, Inc. Becomes Technology Supplier to CHS Farms LLC Press Release Source: GWS Technologies, Inc. On Tuesday March 9, 2010, 9:37 am SCOTTSDALE, Ariz.--(BUSINESS WIRE)--GWS Technologies, Inc. (OTCBB: GWSC - News), an alternative energy company developing renewable energy solutions, announced today that it will start supplying CHS Farms LLC with wind turbines, solar panels, and hydro electric generators. CHS Farms LLC is a 165 acre sustainable integrated aquaponic facility 45 miles northwest of Phoenix, Arizona. "Working with CHS Farms is a tremendous opportunity because the land has the potential to develop over 10MW of solar, wind and hydro power," said GWS Technologies Vice President Michael Coskun. "CHS Farms is able to take advantage of hydro-power thanks to natural gravity flow and over 200,000 gallons of water flowing downhill daily," Mr. Coskun added. "We are very excited to be able to utilize the technologies GWS Tech has to offer," said Dr. Jason Licamele, a project manager at CHS Farms. "We plan to implement environmentally sound standards for producing food and energy by utilizing our natural resources as efficiently as possible in conjunction with modern technologies, this will allow us to get more food production from our water, land, and nutrient resources as compared to conventional agriculture,” Dr. Licamele added. Dr. Licamele received his PhD from the University of Arizona in Agriculture & Biosystems Engineering, and has both a B.S and M.S in Marine Biology. About GWS Technologies, Inc. GWS stands for GreenWindSolar. We are an alternative energy technology company focused on developing, marketing, and implementing solar and wind-powered renewable energy products and solutions for various commercial, industrial, and governmental end-users. We are also building strategic partnerships with companies that are developing cutting-edge technologies and solutions. By harnessing the power of the wind and the sun, we’re helping consumers and businesses generate their own clean power, reduce carbon emissions, and become part of the global energy solution. For more information please visit www.greenwindsolar.com. About CHS Farms LLC CHS Farms is a sustainable integrated farm and through the use of cutting edge aquaculture techniques is raising tilapia fish and produce and markets them to high end restaurants, resorts, and specialty food stores. Safe Harbor Statement:

To: GARY P GROBBEL who wrote (95609)	3/15/2010 9:45:15 AM
From: ACAN	Respond to of 120415

CTS.V Cantronic Acquires Additional Interest in Beijing Advanced Videoinfo Technology Co., Ltd. -Acquisition provides Cantronic complete control over Chinese software company- Press Release Source: Cantronic Systems Inc. On Monday March 15, 2010, 8:00 am EDT VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 15, 2010) - Cantronic Systems Inc., ("Cantronic" or the "Company") (TSX VENTURE:CTS - News), today announced that it has acquired an additional 9.08% interest in Beijing Advanced VideoInfo Technology Co., Ltd. ("AVINFO") for a total of RMB 0.9 million (approximately CDN$0.14 million) in cash, increasing its ownership position to 67.64%. "This transaction provides us with complete control of our China-based software company, AVINFO," said James Zahn, President and Chief Executive Officer of Cantronic. "AVINFO has established its software as one of the leading management platforms for monitoring and surveillance, with small and large installations in more than 60 Chinese cities. As these cities expand their networks they are more likely to choose a proven software solution with a user interface that their staff has been trained on. With AVINFO's software and the hardware from our other Chinese subsidiary, Shenzhen Huanghe Digital Technology Co. Ltd., we have a fully- integrated product offering, which positions us well to capitalize on the burgeoning demand for video surveillance systems in China." Cantronic also agreed to issue up to RMB 2.72 million (approximately CDN$0.42 million) worth of Cantronic common shares to AVINFO management, management consultants and key employees under an earn-out performance-based arrangement. Cantronic common shares to be issued will be based on the market price at the close of this acquisition and will be subject to a lock-up period of two years after the issuance.